MIRA INFORM
REPORT
|
Report Date : |
30.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
MEDOCHEMIE LTD |
|
|
|
|
Registered Office : |
1-10 Constantinoupoleos Str, PO Box 51409, Limassol, 3505 |
|
|
|
|
Country : |
Cyprus |
|
|
|
|
Year of Establishment : |
1976 |
|
|
|
|
Legal Form : |
Private Independent |
|
|
|
|
Line of Business : |
Manufacture of Generic Pharmaceuticals |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Cyprus |
b1 |
b1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Company name & address
Medochemie Ltd
1-10 Constantinoupoleos Str
PO Box 51409
Limassol, 3505
Cyprus
Tel: 357 (25) 86 76 00
Fax: 357 (25) 56 08 63
Web: www.medochemie.com
Synthesis
Employees: 1,250
Company Type: Private Independent
Incorporation Date: 1976
Auditor: KPMG
Reporting Currency: Cyprus
Pound
Annual Sales: NA
Total Assets: NA
Business Description
Manufacture of
generic pharmaceuticals. The company produces a wide variety of products in
oral (solid and liquid), parental, topical and rectal presentation, including
penicillins and cephalosporins produced in strictly isolated facilities. All
aspects, including environmental and safety, are harmonised with EU
requirements
Industry
Industry Biotechnology and Drugs
ANZSIC 2006: 1841 - Human
Pharmaceutical and Medicinal Product Manufacturing
NACE 2002: 2442 - Manufacture
of pharmaceutical preparations
NAICS 2002: 325412 -
Pharmaceutical Preparation Manufacturing
UK SIC 2003: 24421 -
Manufacture of medicaments
US SIC 1987: 2834 -
Pharmaceutical Preparations
Bottom of Form
Key Executives
|
Name |
Title |
|
Andreas Pittas |
Executive Chairman |
news
|
Title |
Date |
|
CYPRUS :
Medochemie LTD bags contract of 22 750 Euros |
22-Jul-2011 |
|
CYPRUS :
Contract of 225654 EUR awarded by Farmakeytikes Ypiresies |
21-Mar-2011 |
|
CYPRUS :
Medochemie Ltd bags contract of 146 400 Euros for supply of vaccines |
26-Feb-2011 |
1 - Profit &
Loss Item Exchange Rate: USD 1 = CYP
2 - Balance Sheet
Item Exchange Rate: USD 1 = CYP
Corporate Overview
Location
1-10
Constantinoupoleos Str
PO Box 51409
Limassol, 3505
Cyprus
Tel: 357 (25) 86 76 00
Fax: 357 (25) 56 08 63
Web: www.medochemie.com
Sales CYP(mil): NA
Assets CYP(mil): NA
Employees: 1,250
Industry: Biotechnology and Drugs
Incorporation
Date: 1976
Company Type: Private Independent
Quoted Status: Not Quoted
Executive
Chairman: Andreas Pittas
Contents
· Industry Codes
· Business Description
· Subsidiaries
· Key Corporate Relationships
Industry Codes
ANZSIC 2006 Codes:
1841 - Human
Pharmaceutical and Medicinal Product Manufacturing
NACE 2002 Codes:
2442 - Manufacture
of pharmaceutical preparations
NAICS 2002 Codes:
325412 - Pharmaceutical
Preparation Manufacturing
US SIC 1987:
2834 - Pharmaceutical
Preparations
UK SIC 2003:
24421 - Manufacture
of medicaments
Business Description
Manufacture of
generic pharmaceuticals. The company produces a wide variety of products in
oral (solid and liquid), parental, topical and rectal presentation, including
penicillins and cephalosporins produced in strictly isolated facilities. All
aspects, including environmental and safety, are harmonised with EU
requirements
|
|
|
|
||||||||||||||||||||||||||||||||||||
Key Corporate Relationships
Auditor: KPMG
Bank: Bank of Cyprus Ltd
Auditor: KPMG
Executive report
Board of Directors
|
|
|
|||
|
Executive Chairman |
Chairman |
CYPRUS : Medochemie LTD bags contract of 22 750
Euros
Mena Report: 22
July 2011
[What follows is
the full text of the news story.]
Farmakeytikes
Ypiresies, Cyprus has issued the contract of 22 750 Euros to Medochemie LTD,
Cyprus for supply of other therapeutic products. Open procedure was followed
for awarding this contract.
The contract is
covered by the Government Procurement Agreement (GPA) and will not be
sub-contracted to third party. Financing for this contract is not done by any
community funds. The contractor is not selected through an electronic auction.
The contracting authority is not purchasing on behalf of other contracting
authorities.
Initial estimated
total value of the contract was 22 204 EUR and the final contract award value
was 22 750 EUR, excluding VAT. The contract has been allotted as per lowest
price criteria. Farmakeytikes Ypiresies, Cyprus is a ministry or any other
national or federal authority, including their regional or local sub-divisions.
CYPRUS : Contract of
225654 EUR awarded by Farmakeytikes Ypiresies
Mena Report: 21 March 2011
[What follows is
the full text of the news story.]
Farmakeytikes
Ypiresies has awarded 225654 EUR contract for supplies of general
anti-infectives for systemic use and vaccines. The procedure through which this
contract is awarded is open.
The contract is
covered by the Government Procurement Agreement (GPA) and will not be
sub-contracted to third party. Financing for this contract is not done by any
community funds. Contract is not awarded by using an electronic auction. The
criteria of lowest price was opted for awarding the contract.
The contract was
divided into lots, which were allotted to Pharmaceutical Trading CO LTD,
Remedica LTD, Medochemie LTD, Varnavas Hadjipanayis LTD, Medilink
Pharmaceuticals LTD. Total ten offers were received for the contract.
CYPRUS :
Medochemie Ltd bags contract of 146 400 Euros for supply of vaccines
Mena Report: 26 February 2011
[What follows is
the full text of the news story.]
Medochemie Ltd,
Cyprus has received the contract of 146 400 Euros from Farmakeytikes Ypiresies,
Cyprus for supply of general anti-infectives for systemic use and vaccines.
Contract received
total 4 offers. GPA has covered this contract with no possibility of sub-contracting.
Initial estimated total value of the contract was 192 000 EUR and the final
contract award value was 146 400 EUR, excluding VAT.
Contract is not
awarded by using an electronic auction. Farmakeytikes Ypiresies is a ministry
or any other national or federal authority, including their regional or local
sub-divisions. The contracting authority is not purchasing on behalf of other
contracting authorities.
CYPRUS :
Medochemie LTD bags contract of 22 750 Euros
TendersInfo News
22 July 2011
[What follows is
the full text of the article.]
Farmakeytikes
Ypiresies, Cyprus has issued the contract of 22 750 Euros to Medochemie LTD,
Cyprus for supply of other therapeutic products. Open procedure was followed
for awarding this contract.
The contract is covered
by the Government Procurement Agreement (GPA) and will not be sub-contracted to
third party. Financing for this contract is not done by any community funds.
The contractor is not selected through an electronic auction. The contracting
authority is not purchasing on behalf of other contracting authorities.
Initial estimated
total value of the contract was 22 204 EUR and the final contract award value
was 22 750 EUR, excluding VAT. The contract has been allotted as per lowest
price criteria. Farmakeytikes Ypiresies, Cyprus is a ministry or any other
national or federal authority, including their regional or local sub-divisions.
Related Geographies
· Europe
· Cyprus
· Greece
CYPRUS : Medochemie Ltd bags contract of 146 400
Euros for supply of vaccines
TendersInfo News
26 February 2011
[What follows is
the full text of the article.]
Medochemie Ltd,
Cyprus has received the contract of 146 400 Euros from Farmakeytikes Ypiresies,
Cyprus for supply of general anti-infectives for systemic use and vaccines.
Contract received
total 4 offers. GPA has covered this contract with no possibility of
sub-contracting. Initial estimated total value of the contract was 192 000 EUR
and the final contract award value was 146 400 EUR, excluding VAT.
Contract is not
awarded by using an electronic auction. Farmakeytikes Ypiresies is a ministry
or any other national or federal authority, including their regional or local
sub-divisions. The contracting authority is not purchasing on behalf of other
contracting authorities.
Related Geographies
· Europe
· Cyprus
· Greece
CYPRUS : Medochemie Ltd acquires medical suppy
contract of 266 661 euros
TendersInfo News
22 November 2010
[What follows is
the full text of the article.]
Farmakeytikes
Ypiresies has allotted the contract of 266 661 euros to Medochemie Ltd, Cyprus.
The contract has been issued to make provision of general anti-infectives for
systemic use and vaccines.
Total three offers
were received by Contracting Authority for participating in this contract;
however finally contract was allotted to Medochemie Ltd, Cyprus.
The contract has
been covered by the Government Procurement Agreement (GPA) and issued as per
open procedure method and lowest price selection criteria. Initial estimated
total value of the contract was 444 902 euros. However, final value of the
contract is 266 661 euros, excluding VAT.
About Medochemie
Ltd - http://www.medochemie.com
Medochemie Ltd, an
international generic pharmaceutical manufacturer, headquartered in Cyprus,
manufactures a wide range of oral solid dosage forms, oral solutions, powder
and solutions for injection, dry powders for inhalation, and creams, ointments,
and suppositories in nine of our manufacturing facilities.
Medochemie Ltd is
a member of EGA (European Generic Medicines Association).
Being an export
oriented company, Medochemie has been granted 13 awards from the government of
Cyprus and three awards from the European Union for outstanding business
performance.
Copyright 2010
Euclid Infotech Pvt. Ltd., distributed by Contify.com
Related Geographies
Europe
Cyprus
Greece
Cyprus : Medochemie bags 60 883,70 EUR contract for
diabetes medicine
TendersInfo News
25 October 2010
[What follows is
the full text of the article.]
Farmakeytikes Ypiresies
a Cyprus based company has awarded contract for medicinal products used in
diabetes to Medochemie Ltd. the procedure of the contract award was open for
all the bidders.
The initial
estimated total value of the contract was 79 849,00 EUR, excluding VAT and
total final value of the contract was 60 883,70 EUR, excluding VAT. The work on
the project will be started in due course.
About Medochemie:
Medochemie owns 18
overseas offices exclusively staffed with professionals of that country.
Medochemie group has 630 products and over 3,800 registrations having acccess
to the healthcare markets of 95 countries. License in and out activities are
also becoming more important and this enables penetration of new markets using
established players in those countries. Medochemie Ltd is an international
generic pharmaceutical company.
Related Geographies
Europe
Cyprus
Greece
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.16 |
|
UK Pound |
1 |
Rs.72.10 |
|
Euro |
1 |
Rs.63.10 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.